-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Eganelisib in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Eganelisib in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Eganelisib in Non-Small Cell Lung Cancer Drug Details: Eganelisib is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Eganelisib in Triple-Negative Breast Cancer (TNBC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Eganelisib in Triple-Negative Breast Cancer (TNBC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Eganelisib in Triple-Negative Breast Cancer (TNBC) Drug Details: Eganelisib is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Eganelisib in Head And Neck Squamous Cell Carcinoma (HNSC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Eganelisib in Head And Neck Squamous Cell Carcinoma (HNSC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Eganelisib in Head And Neck Squamous...
-
Thematic Analysis
Travel and Tourism M&A Deals 2023 – Top Themes – Thematic Intelligence
This report analyzes the disruptive themes that have driven M&A activity in 2023 in the Travel & Tourism Sector
-
Analyst Opinions
Africa Energy Transition Market Trends and Analysis by Sectors and Companies Driving Development
Africa Energy Transition Market Report Overview Africa is set to experience significant social, economic, and environmental changes that will heavily influence the region’s energy demand in the coming years. The power market in Africa still heavily relies on a combination of thermal power and large-scale hydropower projects to meet its power demand. However, the region’s energy transition is gaining pace as countries increasingly capitalize on the falling cost of producing renewable energy and the region’s rich renewable resources, which is...
-
Product Insights
Adrenal Gland Cancer – Drugs In Development, 2023
Global Markets Direct’s, ‘Adrenal Gland Cancer - Drugs In Development, 2023’, provides an overview of the Adrenal Gland Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development for Adrenal Gland Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Adrenocortical Carcinoma (Adrenal Cortex Cancer) – Drugs In Development, 2023
Global Markets Direct’s, ‘Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Drugs In Development, 2023’, provides an overview of the Adrenocortical Carcinoma (Adrenal Cortex Cancer) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Adrenocortical Carcinoma (Adrenal Cortex Cancer), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...